ArticleFrontiers in endocrinology2025

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy.

Tobias Stemann Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.